Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-23-045156

EVP, Chief Financial Officer sold 35,125 shares at $9.73 ($341,889)

From the SEC's structured data for this filing

Trades in this filing

Kalif Eliyahu Sharon · EVP, Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-08-07 Sale : show line 1 in the form −35,125 $9.73 $341,889 99,162 D
Open-market sales · 35,125 sh · avg $9.73 · $341,889
Loading xslF345X05/doc4.xml…